PanGen Biotech Inc (222110) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.122x

Based on the latest financial reports, PanGen Biotech Inc (222110) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.66 Billion ≈ $-2.48 Million USD) by net assets (₩30.03 Billion ≈ $20.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PanGen Biotech Inc balance sheet quality to measure how much of total assets are equity-financed.

PanGen Biotech Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PanGen Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PanGen Biotech Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

PanGen Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PanGen Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GFG Resources Inc V:GFG	-0.012x
SK Innovation Co Ltd Pref KO:096775	-0.011x
Kairous Acquisition Corp Ltd NASDAQ:KACL	-0.008x
Moneyme Ltd AU:MME	0.340x
SelfWealth Limited AU:SWF	0.093x
Yuhan Corp Preferred KO:000105	0.016x
AML3D Ltd AU:AL3	-0.076x
Aimflex Bhd KLSE:0209	0.004x

Annual Cash Flow Conversion Efficiency for PanGen Biotech Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of PanGen Biotech Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see PanGen Biotech Inc (222110) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.91 Billion ≈ $16.88 Million	₩2.99 Billion ≈ $2.02 Million	0.120x	+143.67%
2023-12-31	₩12.57 Billion ≈ $8.52 Million	₩-3.45 Billion ≈ $-2.34 Million	-0.275x	-35.00%
2022-12-31	₩17.22 Billion ≈ $11.67 Million	₩-3.50 Billion ≈ $-2.37 Million	-0.203x	-29.11%
2021-12-31	₩21.10 Billion ≈ $14.30 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.158x	+52.17%
2020-12-31	₩14.21 Billion ≈ $9.63 Million	₩-4.68 Billion ≈ $-3.17 Million	-0.329x	-65.73%
2019-12-31	₩18.43 Billion ≈ $12.49 Million	₩-3.66 Billion ≈ $-2.48 Million	-0.199x	+4.56%
2018-12-31	₩26.94 Billion ≈ $18.26 Million	₩-5.61 Billion ≈ $-3.80 Million	-0.208x	-891.15%
2017-12-31	₩31.31 Billion ≈ $21.22 Million	₩-657.84 Million ≈ $-445.81K	-0.021x	+82.93%
2016-12-31	₩35.31 Billion ≈ $23.93 Million	₩-4.35 Billion ≈ $-2.94 Million	-0.123x	+49.74%
2015-12-31	₩6.56 Billion ≈ $4.45 Million	₩-1.61 Billion ≈ $-1.09 Million	-0.245x	-95.31%
2014-12-31	₩10.69 Billion ≈ $7.24 Million	₩-1.34 Billion ≈ $-908.12K	-0.125x	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$45.36 Million

₩66.93 Billion KRW

Market Cap Rank

#22212 Global

#1358 in Korea

Share Price

₩4960.00

Change (1 day)

+1.22%

52-Week Range

₩4330.00 - ₩7340.00

All Time High

₩24450.00